Endurant Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,185	Closed	-$4.4M	–	40
2023 Q1	$4.4M	Buy	9,185 +5,292	+136%	+$2.48M	2.26%	14
2022 Q4	$1.64M	Sell	3,893 -3,091	-44%	-$1.25M	0.66%	27
2022 Q3	$2.91M	Sell	6,984 -9,044	-56%	-$4.51M	0.95%	27
2022 Q2	$7.93M	Sell	16,028 -1,123	-7%	-$585K	3.03%	14
2022 Q1	$9.66M	Buy	17,151 +2,612	+18%	+$1.57M	2.92%	12
2021 Q4	$11M	Sell	14,539 -3,733	-20%	-$2.79M	2.97%	12
2021 Q3	$13.6M	Buy	18,272 +6,452	+55%	+$4.83M	4.14%	8
2021 Q2	$7.62M	Sell	11,820 -2,964	-20%	-$1.8M	2.09%	16
2021 Q1	$8.44M	Buy	+14,784	New	+$8.75M	2.29%	19
2020 Q4	–	Sell	-3,916	Closed	-$2.02M	–	58
2020 Q3	$2.02M	Buy	3,916 +411	+12%	+$208K	0.7%	44
2020 Q2	$1.58M	Buy	+3,505	New	+$1.55M	0.65%	42
2019 Q4	–	Sell	-6,910	Closed	-$2.3M	–	58
2019 Q3	$2.3M	Buy	6,910 +3,175	+85%	+$1.04M	0.89%	25
2019 Q2	$1.17M	Buy	+3,735	New	+$1.12M	0.46%	42